This Article Full Text Full Text (PDF) All Versions of this Article: 106/15/1938    most recent 01.CIR.0000033221.73082.06v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mills, J. D. Articles by Grant, P. J. Search for Related Content PubMed PubMed Citation Articles by Mills, J. D. Articles by Grant, P. J. Related Collections Fibrinolysis Arterial thrombosis Coagulation Fibrinogen/fibrin Acute coronary syndromes Epidemiology Coagulation and fibronolysis Genetics of cardiovascular disease

(Circulation. 2002;106:1938.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease

From the Academic Unit of Molecular Vascular Medicine, University of Leeds, United Kingdom.

Correspondence to Robert A.S. Ariëns, PhD, Academic Unit of Molecular Vascular Medicine, G Floor, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, United Kingdom. E-mail r.a.s.ariens{at}leeds.ac.uk

Background— A family history of premature coronary artery disease (CAD) is an independent cardiovascular risk factor. Fibrin clots composed of dense fiber networks are found in young CAD patients and may occur in the relatives of such individuals.

Methods and Results— The ex vivo fibrin structure of 100 healthy male relatives of patients with premature CAD and 100 age-matched control subjects was assessed by measurement of permeability (K_s), fiber mass-length ratio (µ), and turbidity (lag phase and maximum absorbency [max Abs]). Scanning electron microscopy was performed on selected samples. Relatives and controls shared similar levels of conventional cardiovascular risk factors. K_s was lower in relatives than in controls, 12.2 (11.1 to 13.3) versus 15.2 (14.0 to 16.5) x10^-9 cm² (P<0.001), associated with a smaller decrease in µ, 8.5 (7.7 to 9.2) versus 9.7 (8.9 to 10.5) x 10¹³ Da/cm (P<0.05), respectively. Lag phase was shorter in relatives than in controls, 39 (37 to 41) versus 47 (44 to 50) seconds (P<0.001), and max Abs was higher in relatives, 0.78 (0.74 to 0.82) versus 0.71 (0.67 to 0.74) in controls (P=0.02), which indicates the presence of thicker fibers in relatives. After adjustment for fibrinogen levels, lag phase and K_s remained significantly different between relatives and control subjects. Scanning electron microscopy images confirmed increased fiber diameter in relatives, possibly of reduced density. Factor XIII Val34Leu and fibrinogen A Thr312Ala and Bß -455 G/A showed no association with clot structure.

Conclusions— The male relatives of patients with premature CAD form fibrin clots that begin polymerization more quickly, have thicker fibers, and are less permeable than those of control subjects.

Key Words: fibrin structure • fibrinogen • coronary disease • thrombosis • fibrinolysis

This article has been cited by other articles:

				R. S. Barua, F. Sy, S. Srikanth, G. Huang, U. Javed, C. Buhari, D. Margosan, and J. A. Ambrose Effects of Cigarette Smoke Exposure on Clot Dynamics and Fibrin Structure: An Ex Vivo Investigation Arterioscler Thromb Vasc Biol, January 1, 2010; 30(1): 75 - 79. [Abstract] [Full Text] [PDF]

				R. A. S. Ariens Denser matters Blood, November 5, 2009; 114(19): 3978 - 3979. [Full Text] [PDF]

				A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydlowska, A. Skubiszak, K. Ciepluch, and W. Tracz Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood, November 5, 2009; 114(19): 4272 - 4278. [Abstract] [Full Text] [PDF]

				A. Undas, P. Podolec, K. Zawilska, M. Pieculewicz, I. Jedlinski, E. Stepien, E. Konarska-Kuszewska, P. Weglarz, M. Duszynska, E. Hanschke, et al. Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke Stroke, April 1, 2009; 40(4): 1499 - 1501. [Abstract] [Full Text] [PDF]

				I. Parastatidis, L. Thomson, A. Burke, I. Chernysh, C. Nagaswami, J. Visser, S. Stamer, D. C. Liebler, G. Koliakos, H. F. G. Heijnen, et al. Fibrinogen {beta}-Chain Tyrosine Nitration Is a Prothrombotic Risk Factor J. Biol. Chem., December 5, 2008; 283(49): 33846 - 33853. [Abstract] [Full Text] [PDF]

				A. Undas, I. Wiek, E. Stepien, K. Zmudka, and W. Tracz Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome Diabetes Care, August 1, 2008; 31(8): 1590 - 1595. [Abstract] [Full Text] [PDF]

				A. Undas, M. Kolarz, G. Kopec, and W. Tracz Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2010 - 2015. [Abstract] [Full Text] [PDF]

				A. M. Carter, C. M. Cymbalista, T. D. Spector, P. J. Grant, and on behalf of the EuroCLOT Investigators Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2783 - 2789. [Abstract] [Full Text] [PDF]

				J. Zalewski, A. Undas, J. Godlewski, E. Stepien, and K. Zmudka No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2258 - 2265. [Abstract] [Full Text] [PDF]

				H. S. Al-Barjas, R. Ariens, P. Grant, and J. A. Scott Raised Plasma Fibrinogen Concentration in Patients With Abdominal Aortic Aneurysm Angiology, October 1, 2006; 57(5): 607 - 614. [Abstract] [PDF]

				B. Keavney, J. Danesh, S. Parish, A. Palmer, S. Clark, L. Youngman, M. Delepine, M. Lathrop, R. Peto, R. Collins, et al. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization' Int. J. Epidemiol., August 1, 2006; 35(4): 935 - 943. [Abstract] [Full Text] [PDF]

				A. Undas, J. Brozek, M. Jankowski, Z. Siudak, A. Szczeklik, and H. Jakubowski Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1397 - 1404. [Abstract] [Full Text] [PDF]

				E. M. Scott, R. A.S. Ariens, and P. J. Grant Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1558 - 1566. [Abstract] [Full Text] [PDF]

				E. J. Dunn, R. A. Ariens, M. de Lange, H. Snieder, J. H. Turney, T. D. Spector, and P. J. Grant Genetics of fibrin clot structure: a twin study Blood, March 1, 2004; 103(5): 1735 - 1740. [Abstract] [Full Text] [PDF]

				J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 382 - 386. [Abstract] [Full Text]

				A. V. Cooper, K. F. Standeven, and R. A. S. Ariens Fibrinogen gamma-chain splice variant {gamma}' alters fibrin formation and structure Blood, July 15, 2003; 102(2): 535 - 540. [Abstract] [Full Text] [PDF]

				K. F. Standeven, P. J. Grant, A. M. Carter, T. Scheiner, J. W. Weisel, and R. A.S. Ariens Functional Analysis of the Fibrinogen A{alpha} Thr312Ala Polymorphism: Effects on Fibrin Structure and Function Circulation, May 13, 2003; 107(18): 2326 - 2330. [Abstract] [Full Text] [PDF]